Related Experiment Video
Updated: Jun 4, 2026
Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014
Imaging cellular receptors in breast cancers: an overview
Thillai V Sekar1, Aradhana Dhanabalan, Ramasamy Paulmurugan
1Molecular Imaging Program at Stanford, Canary Center at Stanford, Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304, USA.
Abstract:
Breast cancer, a leading cause of cancer death in women, is strongly correlated with the up- and down-regulation of hormone and growth factor receptors. Therefore, improving our understanding of such receptor status in different stages of breast cancer will help in the development of novel diagnostic and therapeutic solutions. In particular, molecular imaging technology in association with advanced molecular and cell biology techniques could reveal in detail dynamic molecular events in cells, allowing the study of crucial molecular pathological changes occurring in cancer and other diseases. Molecular imaging techniques such as PET, SPECT, MRI, and the combinatorial techniques have made tremendous strides in elucidating the role of cellular receptors, helping to monitor the course of breast cancer development and the therapeutic efficacy of novel drugs. Optical imaging of cellular receptors is emerging as a powerful tool given the advancement of fluorescent and bioluminescent proteins. Estrogen receptor, progesterone receptor, and HER2/neu have been adopted clinically to detect different types of breast cancer and to test novel treatment strategies; however, other cellular receptors may also be involved in breast cancer subtyping and could emerge as treatment prospects. This review will focus on the recent developments of imaging various cellular receptors pertaining to the growth and development of breast cancer.
Insights
Understanding hormone and growth factor receptors in breast cancer is key for new treatments. Molecular imaging advances help track cancer development and drug effectiveness, offering new diagnostic and therapeutic insights.
Area of Science:
- Oncology
- Molecular Imaging
- Biotechnology
Background:
- Breast cancer is a major cause of cancer death in women, closely linked to hormone and growth factor receptor expression.
- Understanding receptor status across breast cancer stages is crucial for developing new diagnostic and therapeutic strategies.
- Molecular imaging, combined with advanced cell biology, offers detailed insights into dynamic cellular events and pathological changes in cancer.
Purpose of the Study:
- To review recent advancements in imaging cellular receptors involved in breast cancer growth and development.
- To highlight the role of molecular imaging in understanding receptor dynamics and their implications for breast cancer.
- To explore the potential of novel cellular receptors as therapeutic targets and for breast cancer subtyping.
Main Methods:
- Review of molecular imaging techniques including PET, SPECT, MRI, and optical imaging (fluorescent and bioluminescent proteins).
- Integration of advanced molecular and cell biology techniques to study cellular receptors.
- Analysis of clinical applications of receptor imaging in breast cancer detection and treatment monitoring.
Main Results:
- Molecular imaging techniques have significantly advanced the understanding of cellular receptor roles in cancer.
- Estrogen receptor, progesterone receptor, and HER2/neu are clinically established biomarkers for breast cancer detection and treatment.
- Emerging research indicates other cellular receptors may play roles in breast cancer subtyping and represent potential therapeutic targets.
Conclusions:
- Molecular imaging is a powerful tool for studying cellular receptors in breast cancer, aiding in monitoring disease progression and treatment response.
- Further research into novel cellular receptors and advanced imaging techniques can lead to improved diagnostic and therapeutic strategies for breast cancer.
- The integration of molecular imaging and cell biology provides a comprehensive approach to understanding and combating breast cancer.
